C4 Therapeutics Correlations

CCCC Stock  USD 2.32  0.14  6.42%   
The current 90-days correlation between C4 Therapeutics and Foghorn Therapeutics is 0.44 (i.e., Very weak diversification). The correlation of C4 Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

C4 Therapeutics Correlation With Market

Modest diversification

The correlation between C4 Therapeutics and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in C4 Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade CCCC Stock refer to our How to Trade CCCC Stock guide.

Moving together with CCCC Stock

  0.63JNJ Johnson JohnsonPairCorr
  0.66MRK Merck CompanyPairCorr
  0.63SHG Shinhan Financial Earnings Call This WeekPairCorr
  0.67WF Woori Financial Group Earnings Call This WeekPairCorr
  0.7BAC-PL Bank of AmericaPairCorr
  0.63WFC-PL Wells FargoPairCorr
  0.62INTC Intel Earnings Call This WeekPairCorr
  0.66CVX Chevron CorpPairCorr

Moving against CCCC Stock

  0.7PG Procter GamblePairCorr
  0.34KO Coca Cola Earnings Call This WeekPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NRIXKYMR
NRIXGLUE
GLUEFHTX
KYMRFHTX
PRLDSTTK
KYMRGLUE
  
High negative correlations   
LUNGKYMR
LUNGFHTX
GLUESTTK
STTKFHTX
LUNGNRIX
LUNGSTTK

Risk-Adjusted Indicators

There is a big difference between CCCC Stock performing well and C4 Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze C4 Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

C4 Therapeutics Corporate Management

Paige MahaneyChief OfficerProfile
Kelly SchickChief OfficerProfile
Isabel ChiuSenior DevelopmentProfile
Mr MBAChief OfficerProfile
Andrew HirschPres CEOProfile
Leonard MDChief OfficerProfile